The impact of somatostatin receptor–directed PET/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis
M Barrio, J Czernin, S Fanti, V Ambrosini… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. 68Ga-DOTATATE approval by the US Food and Drug …
neuroendocrine tumor (NET) patients. 68Ga-DOTATATE approval by the US Food and Drug …
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
M Barrio, J Czernin, S Fanti… - Journal of Nuclear …, 2017 - epub.ub.uni-muenchen.de
Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. 68Ga-DOTATATE approval by the US Food and Drug …
neuroendocrine tumor (NET) patients. 68Ga-DOTATATE approval by the US Food and Drug …
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.
M Barrio, J Czernin, S Fanti, V Ambrosini… - Journal of Nuclear …, 2017 - europepmc.org
Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. 68 Ga-DOTATATE approval by the US Food and Drug …
neuroendocrine tumor (NET) patients. 68 Ga-DOTATATE approval by the US Food and Drug …
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
M Barrio, J Czernin, S Fanti… - Journal of nuclear …, 2017 - pubmed.ncbi.nlm.nih.gov
Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. 68 Ga-DOTATATE approval by the US Food and Drug …
neuroendocrine tumor (NET) patients. 68 Ga-DOTATATE approval by the US Food and Drug …
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.
M Barrio, J Czernin, S Fanti, V Ambrosini, I Binse, L Du… - 2017 - mediatum.ub.tum.de
Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. Ga-DOTATATE approval by the US Food and Drug …
neuroendocrine tumor (NET) patients. Ga-DOTATATE approval by the US Food and Drug …
[PDF][PDF] The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
M Barrio, J Czernin, S Fanti, V Ambrosini… - THE JOURNAL OF …, 2017 - scholar.archive.org
Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. 68Ga-DOTATATE approval by the US Food and Drug …
neuroendocrine tumor (NET) patients. 68Ga-DOTATATE approval by the US Food and Drug …
The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
M Barrio, J Czernin, S Fanti, V Ambrosini… - THE JOURNAL OF …, 2017 - cris.unibo.it
Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients.(68) Ga-DOTATATE approval by the US Food and …
neuroendocrine tumor (NET) patients.(68) Ga-DOTATATE approval by the US Food and …
[引用][C] The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
M Barrio, J Czernin, S Fanti, V Ambrosini… - Journal of Nuclear …, 2017 - cir.nii.ac.jp
The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with
Neuroendocrine Tumor: A Systematic Review and Meta-Analysis | CiNii Research CiNii 国立 …
Neuroendocrine Tumor: A Systematic Review and Meta-Analysis | CiNii Research CiNii 国立 …
[引用][C] The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
M Barrio, J Czernin, S Fanti, V Ambrosini, I Binse… - Journal of Nuclear …, 2017 - osti.gov
The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with
Neuroendocrine Tumor: A Systematic Review and Meta-Analysis (Journal Article) | OSTI.GOV …
Neuroendocrine Tumor: A Systematic Review and Meta-Analysis (Journal Article) | OSTI.GOV …
[PDF][PDF] The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
M Barrio, J Czernin, S Fanti, V Ambrosini… - THE JOURNAL OF …, 2017 - Soc Nuclear Med
Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. 68Ga-DOTATATE approval by the US Food and Drug …
neuroendocrine tumor (NET) patients. 68Ga-DOTATATE approval by the US Food and Drug …